With antibodies having implications for both our understanding of previous coronavirus infections and potential future immunity, Nicola Davis talks to Prof Eleanor Riley about how best to test for them and asks whether antibodies are the only thing we should be looking for.
The Economist Morning Briefing, July 14th, 2020: Coronavirus cases surpass 13m and China and America trade insults.
Coronavirus cases are on the rise in 33 states — and California and Florida hit record high numbers of daily cases last week. Now, hospitals and other medical facilities are feeling déjà vu, as they start to experience personal protective equipment shortages again.
- Plus, Roger Stone talks to Axios’ Mike Allen 48 hours after President Trump commuted his sentence.
- And, the massive rise of alternative meat sales means a fundamental change for the American diet.
Guests: Axios’ Bob Herman, Mike Allen and Bryan Walsh.
From McKinsey & Company (July 9, 2020):
The World Health Organization recently acknowledged that some evidence about in-room transmission is worrisome. In addition, after analyzing a transmission event at a restaurant in China, the US Centers for Disease Control and Prevention (CDC) concluded that an asymptomatic patient transmitted the virus to families at two nearby tables.
Based on the restaurant layout, seating arrangements, and smear samples from air-conditioning inlets and outlets, the CDC found that the coronavirus was likely transmitted when strong airflows from a nearby air conditioner spread large droplets from the infected person. These droplets traveled more than one meter—further than usual, but less than the distance aerosols can typically travel.
New York Times columnist David Brooks and Washington Post columnist Jonathan Capehart join Judy Woodruff to discuss the latest political news, including how the surging coronavirus is affecting President Trump’s public support, the significance of the Supreme Court’s recent rulings and presumptive Democratic presidential nominee Joe Biden’s economic policy recommendations.
Nature discusses the massive coronavirus outbreak that struck the iconic Californian prison after it rejected expert aid.
In this episode:
01:47 Disaster in San Quentin
San Quentin prison is facing a massive outbreak, we dig into how they got there. The crisis has arisen despite warnings from experts, and offers of free tests, which were declined. We ask why? And what can be done now?
29:51 One good thing
For the last episode of Coronapod, our hosts pick out ways that the pandemic has changed them for the better, including professional flexibility, a renewed focus on the power of reporting and time with family
36:07 Lockdown and children’s health
Reporter Stewart asks if lockdowns could have any lasting impact on her young children – what evidence is there on the effect of isolation on young minds?
Will the coronavirus pandemic lead to long-term changes in how we shop for food? To better understand the challenges facing grocery stores, WSJ’s Alexander Hotz spoke with an industry insider, a store owner and a Walmart executive.
Contributing correspondent Kai Kupferschmidt talks with host Sarah Crespi about the success of a fast moving megatrial for coronavirus treatments. The United Kingdom’s Recovery (Randomized Evaluation of COVID-19 Therapy) trial has enrolled more than 12,000 hospitalized coronavirus patients since early March and has released important recommendations that were quickly taken up by doctors and scientists around the world.
Kupferschmidt discusses why such a large study is necessary and why other large drug trials like the World Health Organization’s Solidarity trial are lagging behind. Also this week, producer Meagan Cantwell talks with Saul Villeda, a professor in the Department of Anatomy at the University of California, San Francisco, about transferring the beneficial effects of exercise on the brain from an active mouse to a sedentary mouse by transferring their blood.
Public health organizations track the spread of coronavirus and use graphs and charts to visualize the data. WSJ’s Brianna Abbott explains what to look for in the data to understand how the virus is impacting your community.
Photo illustration: Laura Kammermann/WSJ